Finance

Beta
Lists
IOVA:NASDAQ
Iovance Biotherapeutics Inc
$3.96
-3.41%
(-0.14) 1D
$3.97
+0.25% (+0.0100)
After hours
Closed: Jun 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IOVA...
Open
$4.11
High
$4.20
Low
$3.90
Mkt. cap
1.77B
Avg. vol.
14.70M
Volume
14.46M
52-wk high
$5.63
52-wk low
$1.66
EPS
-$0.95
Beta
0.69
Shares outstanding
446.50M
No. of employees
975
Open
$4.11
High
$4.20
Low
$3.90
Mkt. cap
1.77B
Avg. vol.
14.70M
Volume
14.46M
52-wk high
$5.63
52-wk low
$1.66
EPS
-$0.95
Beta
0.69
Shares outstanding
446.50M
No. of employees
975
News stories
From sources across the web
Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
About Iovance Biotherapeutics Inc
CEO-
Employees975
Founded2007
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Websiteiovance.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
59.95M
67.46M
86.77M
71.43M
Cost of goods sold
56.66M
38.48M
43.11M
42.50M
Cost of revenue
56.66M
38.48M
43.11M
42.50M
Research and development expenses
79.36M
75.17M
71.20M
62.49M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.70M
34.56M
36.40M
38.95M
Operating expense
117.06M
118.74M
117.12M
109.98M
Total operating expenses
173.73M
157.21M
160.23M
152.47M
Operating income
-113.77M
-89.76M
-73.46M
-81.04M
Other non operating income
-
-
-2.71M
-
EBT including unusual items
-109.67M
-93.66M
-71.72M
-79.71M
EBT excluding unusual items
-109.67M
-88.52M
-73.06M
-80.83M
Income tax expense
1.99M
-2.40M
184.00K
-665.00K
Effective tax rate
-1.81%
2.57%
-0.26%
0.83%
Other operating expenses
-
-
-
-
Net income
-111.66M
-91.25M
-71.90M
-79.04M
Net profit margin
-186.25%
-135.28%
-82.87%
-110.66%
Earnings per share
-0.33
-0.25
-0.18
-0.19
Interest and investment income
4.10M
1.24M
3.10M
213.00K
Interest expense
-
-
-
-
Net interest expenses
4.10M
1.24M
3.10M
213.00K
Depreciation and amortization charges
-
9.01M
9.52M
8.54M
EBITDA
-104.71M
-81.00M
-63.53M
-72.50M
Gain or loss from assets sale
-
-
-
28.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer